Jump to ContentJump to Main Navigation
Innovation for the 21st CenturyHarnessing the Power of Intellectual Property and Antitrust Law$
Users without a subscription are not able to see the full content.

Michael A. Carrier

Print publication date: 2009

Print ISBN-13: 9780195342581

Published to Oxford Scholarship Online: May 2009

DOI: 10.1093/acprof:oso/9780195342581.001.0001

Show Summary Details
Page of

PRINTED FROM OXFORD SCHOLARSHIP ONLINE (www.oxfordscholarship.com). (c) Copyright Oxford University Press, 2019. All Rights Reserved. An individual user may print out a PDF of a single chapter of a monograph in OSO for personal use. date: 22 August 2019

Innovation Markets: Saving Lives and Money in the Pharmaceutical Industry

Innovation Markets: Saving Lives and Money in the Pharmaceutical Industry

Chapter:
(p.295) 13 INNOVATION MARKETS: SAVING LIVES AND MONEY IN THE PHARMACEUTICAL INDUSTRY
Source:
Innovation for the 21st Century
Author(s):

Michael A. Carrier

Publisher:
Oxford University Press
DOI:10.1093/acprof:oso/9780195342581.003.0013

This chapter begins by defining innovation markets, which are markets for research and development (R&D). It then sets forth the critiques that have been leveled against the markets. It proposes a new five-part test for the antitrust enforcement agencies—the U.S. Department of Justice (DOJ) and FTC—to apply to innovation markets. The test improves the current analysis by replacing the seemingly ad hoc approach with a comprehensive framework based on the Merger Guidelines. It also breaks new ground in considering not just the number of firms in research and development but also their respective stages of U.S. Food and Drug Administration (FDA) review. The chapter provides background on preclinical studies as well as clinical trials. It concludes by presenting the results of five case studies from the past two decades—four mergers that the FTC challenged and one that it did not.

Keywords:   innovation market, R&D, Schumpeter, Arrow, drastic innovation, FDA, Federal Trade Commission, Preclinical studies, clinical trials, Pompe disease

Oxford Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.

Please, subscribe or login to access full text content.

If you think you should have access to this title, please contact your librarian.

To troubleshoot, please check our FAQs , and if you can't find the answer there, please contact us .